메뉴 건너뛰기




Volumn 71, Issue 2, 2015, Pages 385-393

Vascular endothelial growth factor: Therapeutic possibilities and challenges for the treatment of ischemia

Author keywords

Human development; Infarction; Injury; Ischemia; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A;

EID: 84921265989     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.08.005     Document Type: Review
Times cited : (89)

References (106)
  • 1
    • 0035124911 scopus 로고    scopus 로고
    • Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance
    • Bosio P.M., et al. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am J Obstet Gynecol 2001, 184(2):146-152.
    • (2001) Am J Obstet Gynecol , vol.184 , Issue.2 , pp. 146-152
    • Bosio, P.M.1
  • 2
    • 0037699954 scopus 로고    scopus 로고
    • The biology of VEGF and its receptors
    • Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9(6):669-676.
    • (2003) Nat Med , vol.9 , Issue.6 , pp. 669-676
    • Ferrara, N.1    Gerber, H.P.2    LeCouter, J.3
  • 3
    • 33344467123 scopus 로고    scopus 로고
    • VEGF function in vascular pathogenesis
    • Ng Y.S., Krilleke D., Shima D.T. VEGF function in vascular pathogenesis. Exp Cell Res 2006, 312(5):527-537.
    • (2006) Exp Cell Res , vol.312 , Issue.5 , pp. 527-537
    • Ng, Y.S.1    Krilleke, D.2    Shima, D.T.3
  • 4
    • 84921266771 scopus 로고    scopus 로고
    • Improving cardiovascular outcomes in rheumatic diseases: therapeutic potential of circulating endothelial progenitor cells
    • Reynolds J.A., et al. Improving cardiovascular outcomes in rheumatic diseases: therapeutic potential of circulating endothelial progenitor cells. Pharmacol Ther 2013.
    • (2013) Pharmacol Ther
    • Reynolds, J.A.1
  • 5
    • 34548443831 scopus 로고    scopus 로고
    • Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition
    • Holmes K., et al. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007, 19(10):2003-2012.
    • (2007) Cell Signal , vol.19 , Issue.10 , pp. 2003-2012
    • Holmes, K.1
  • 6
    • 35748983824 scopus 로고    scopus 로고
    • Roles for VEGF in the adult
    • Maharaj A.S., D'Amore P.A. Roles for VEGF in the adult. Microvasc Res 2007, 74(2-3):100-113.
    • (2007) Microvasc Res , vol.74 , Issue.2-3 , pp. 100-113
    • Maharaj, A.S.1    D'Amore, P.A.2
  • 7
    • 0035167615 scopus 로고    scopus 로고
    • Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies
    • List A.F. Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies. Oncologist 2001, 6(Suppl: 5):24-31.
    • (2001) Oncologist , vol.6 , pp. 24-31
    • List, A.F.1
  • 8
    • 0034000338 scopus 로고    scopus 로고
    • Prognostic value of vascular endothelial growth factor in breast cancer
    • Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 2000, 5(Suppl: 1):37-44.
    • (2000) Oncologist , vol.5 , pp. 37-44
    • Gasparini, G.1
  • 9
    • 0031737424 scopus 로고    scopus 로고
    • MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas
    • Zietz C., et al. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas. Am J Pathol 1998, 153(5):1425-1433.
    • (1998) Am J Pathol , vol.153 , Issue.5 , pp. 1425-1433
    • Zietz, C.1
  • 11
    • 84869869502 scopus 로고    scopus 로고
    • The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells
    • Albrecht-Schgoer K., et al. The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells. Circulation 2012, 126(21):2491-2501.
    • (2012) Circulation , vol.126 , Issue.21 , pp. 2491-2501
    • Albrecht-Schgoer, K.1
  • 12
    • 84862768329 scopus 로고    scopus 로고
    • Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms
    • Finley S.D., Popel A.S. Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms. AAPS J 2012, 14(3):500-509.
    • (2012) AAPS J , vol.14 , Issue.3 , pp. 500-509
    • Finley, S.D.1    Popel, A.S.2
  • 13
    • 0035062394 scopus 로고    scopus 로고
    • The splice variants of vascular endothelial growth factor (VEGF) and their receptors
    • Robinson C.J., Stringer S.E. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 2001, 114(Pt 5):853-865.
    • (2001) J Cell Sci , vol.114 , pp. 853-865
    • Robinson, C.J.1    Stringer, S.E.2
  • 14
    • 0032907687 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF) and its receptors
    • Neufeld G., et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J: Official Publ Fed Am Soc Exp Biol 1999, 13(1):9-22.
    • (1999) FASEB J: Official Publ Fed Am Soc Exp Biol , vol.13 , Issue.1 , pp. 9-22
    • Neufeld, G.1
  • 15
    • 14044271973 scopus 로고    scopus 로고
    • Transcriptional regulation of vascular endothelial growth factor in cancer
    • Loureiro R.M., D'Amore P.A. Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine Growth Factor Rev 2005, 16(1):77-89.
    • (2005) Cytokine Growth Factor Rev , vol.16 , Issue.1 , pp. 77-89
    • Loureiro, R.M.1    D'Amore, P.A.2
  • 16
    • 0029761644 scopus 로고    scopus 로고
    • Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
    • Forsythe J.A., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996, 16(9):4604-4613.
    • (1996) Mol Cell Biol , vol.16 , Issue.9 , pp. 4604-4613
    • Forsythe, J.A.1
  • 17
    • 2942616541 scopus 로고    scopus 로고
    • RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells
    • Shie J.L., et al. RTEF-1, a novel transcriptional stimulator of vascular endothelial growth factor in hypoxic endothelial cells. J Biol Chem 2004, 279(24):25010-25016.
    • (2004) J Biol Chem , vol.279 , Issue.24 , pp. 25010-25016
    • Shie, J.L.1
  • 18
    • 41549105367 scopus 로고    scopus 로고
    • Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B-but not JNK-dependent mechanism
    • Crisostomo P.R., et al. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B-but not JNK-dependent mechanism. Am J Physiol Cell Physiol 2008, 294(3):C675-C682.
    • (2008) Am J Physiol Cell Physiol , vol.294 , Issue.3 , pp. C675-C682
    • Crisostomo, P.R.1
  • 19
    • 0031974158 scopus 로고    scopus 로고
    • Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
    • Murohara T., et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 1998, 97(1):99-107.
    • (1998) Circulation , vol.97 , Issue.1 , pp. 99-107
    • Murohara, T.1
  • 20
    • 0036331674 scopus 로고    scopus 로고
    • A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans
    • Eppler S.M., et al. A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans. Clin Pharmacol Ther 2002, 72(1):20-32.
    • (2002) Clin Pharmacol Ther , vol.72 , Issue.1 , pp. 20-32
    • Eppler, S.M.1
  • 21
    • 53549094683 scopus 로고    scopus 로고
    • A compartment model of VEGF distribution in blood, healthy and diseased tissues
    • Stefanini M.O., et al. A compartment model of VEGF distribution in blood, healthy and diseased tissues. BMC Syst Biol 2008, 2:77.
    • (2008) BMC Syst Biol , vol.2 , pp. 77
    • Stefanini, M.O.1
  • 23
    • 84884189971 scopus 로고    scopus 로고
    • Fcgamma receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies
    • Justiniano S.E., et al. Fcgamma receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies. J Biol Chem 2013, 288(37):26800-26809.
    • (2013) J Biol Chem , vol.288 , Issue.37 , pp. 26800-26809
    • Justiniano, S.E.1
  • 24
    • 11144297756 scopus 로고    scopus 로고
    • Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice
    • Hiratsuka S., et al. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice. Mol Cell Biol 2005, 25(1):346-354.
    • (2005) Mol Cell Biol , vol.25 , Issue.1 , pp. 346-354
    • Hiratsuka, S.1
  • 25
    • 0030751493 scopus 로고    scopus 로고
    • Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia
    • Gerber H.P., et al. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 1997, 272(38):23659-23667.
    • (1997) J Biol Chem , vol.272 , Issue.38 , pp. 23659-23667
    • Gerber, H.P.1
  • 26
    • 0029758798 scopus 로고    scopus 로고
    • Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia
    • Waltenberger J., et al. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 1996, 94(7):1647-1654.
    • (1996) Circulation , vol.94 , Issue.7 , pp. 1647-1654
    • Waltenberger, J.1
  • 27
    • 0030609013 scopus 로고    scopus 로고
    • Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells
    • Barleon B., et al. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 1997, 57(23):5421-5425.
    • (1997) Cancer Res , vol.57 , Issue.23 , pp. 5421-5425
    • Barleon, B.1
  • 28
    • 0030600969 scopus 로고    scopus 로고
    • VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane
    • Wilting J., et al. VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane. Dev Biol 1996, 176(1):76-85.
    • (1996) Dev Biol , vol.176 , Issue.1 , pp. 76-85
    • Wilting, J.1
  • 29
    • 84871611836 scopus 로고    scopus 로고
    • FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update
    • Gordon K., et al. FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update. Hum Mutat 2013, 34(1):23-31.
    • (2013) Hum Mutat , vol.34 , Issue.1 , pp. 23-31
    • Gordon, K.1
  • 30
    • 0033522927 scopus 로고    scopus 로고
    • Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner
    • Fujio Y., Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 1999, 274(23):16349-16354.
    • (1999) J Biol Chem , vol.274 , Issue.23 , pp. 16349-16354
    • Fujio, Y.1    Walsh, K.2
  • 31
    • 33646107369 scopus 로고    scopus 로고
    • VEGF receptor signalling - in control of vascular function
    • Olsson A.K., et al. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 2006, 7(5):359-371.
    • (2006) Nat Rev Mol Cell Biol , vol.7 , Issue.5 , pp. 359-371
    • Olsson, A.K.1
  • 32
    • 0032557564 scopus 로고    scopus 로고
    • Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
    • Gerber H.P., Dixit V., Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998, 273(21):13313-13316.
    • (1998) J Biol Chem , vol.273 , Issue.21 , pp. 13313-13316
    • Gerber, H.P.1    Dixit, V.2    Ferrara, N.3
  • 33
    • 0035174001 scopus 로고    scopus 로고
    • The role of FGF and VEGF in angioblast induction and migration during vascular development
    • Poole T.J., Finkelstein E.B., Cox C.M. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn: Official Pub Am Assoc Anatomists 2001, 220(1):1-17.
    • (2001) Dev Dyn: Official Pub Am Assoc Anatomists , vol.220 , Issue.1 , pp. 1-17
    • Poole, T.J.1    Finkelstein, E.B.2    Cox, C.M.3
  • 34
    • 0033566938 scopus 로고    scopus 로고
    • Multiple developmental roles of VEGF suggested by a LacZ-tagged allele
    • Miquerol L., et al. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. Dev Biol 1999, 212(2):307-322.
    • (1999) Dev Biol , vol.212 , Issue.2 , pp. 307-322
    • Miquerol, L.1
  • 35
    • 84888303236 scopus 로고    scopus 로고
    • Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid
    • Kim A., et al. Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid. Placenta 2013, 34(10):873-878.
    • (2013) Placenta , vol.34 , Issue.10 , pp. 873-878
    • Kim, A.1
  • 36
    • 34250029921 scopus 로고    scopus 로고
    • Genetic polymorphisms for vascular endothelial growth factor in perinatal complications
    • Banyasz I., et al. Genetic polymorphisms for vascular endothelial growth factor in perinatal complications. Eur Cytokine Network 2006, 17(4):266-270.
    • (2006) Eur Cytokine Network , vol.17 , Issue.4 , pp. 266-270
    • Banyasz, I.1
  • 37
    • 84884578824 scopus 로고    scopus 로고
    • Chronic morbidities of premature newborns
    • Balla G., Szabo M. Chronic morbidities of premature newborns. Orv Hetil 2013, 154(38):1498-1511.
    • (2013) Orv Hetil , vol.154 , Issue.38 , pp. 1498-1511
    • Balla, G.1    Szabo, M.2
  • 38
    • 17444391278 scopus 로고    scopus 로고
    • Vascular endothelial growth factor in preterm infants with respiratory distress syndrome
    • Tsao P.N., et al. Vascular endothelial growth factor in preterm infants with respiratory distress syndrome. Pediatr Pulmonol 2005, 39(5):461-465.
    • (2005) Pediatr Pulmonol , vol.39 , Issue.5 , pp. 461-465
    • Tsao, P.N.1
  • 39
    • 84894432213 scopus 로고    scopus 로고
    • Cord blood biomarkers of vascular endothelial growth (VEGF and sFlt-1) and postnatal growth: a preterm birth cohort study
    • Voller S.B., et al. Cord blood biomarkers of vascular endothelial growth (VEGF and sFlt-1) and postnatal growth: a preterm birth cohort study. Early Human Dev 2014, 90(4):195-200.
    • (2014) Early Human Dev , vol.90 , Issue.4 , pp. 195-200
    • Voller, S.B.1
  • 40
    • 79955115575 scopus 로고    scopus 로고
    • In vivo monitoring of fetoplacental VEGFR2 gene activity in a murine pregnancy model using a VEGFR2-luc reporter gene and bioluminescent imaging
    • Greene J.M., et al. In vivo monitoring of fetoplacental VEGFR2 gene activity in a murine pregnancy model using a VEGFR2-luc reporter gene and bioluminescent imaging. Reprod Biol Endocrinol: RB&E 2011, 9:51.
    • (2011) Reprod Biol Endocrinol: RB&E , vol.9 , pp. 51
    • Greene, J.M.1
  • 41
    • 0025669875 scopus 로고
    • Breast milk and neonatal necrotising enterocolitis
    • Lucas A., Cole T.J. Breast milk and neonatal necrotising enterocolitis. Lancet 1990, 336(8730):1519-1523.
    • (1990) Lancet , vol.336 , Issue.8730 , pp. 1519-1523
    • Lucas, A.1    Cole, T.J.2
  • 42
    • 0032955187 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells
    • Siafakas C.G., et al. Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells. Pediatr Res 1999, 45(5 Pt 1):652-657.
    • (1999) Pediatr Res , vol.45 , Issue.5 , pp. 652-657
    • Siafakas, C.G.1
  • 43
    • 84862492014 scopus 로고    scopus 로고
    • Comparison of the levels of the growth factors in umbilical cord serum and human milk and its clinical significance
    • Patki S., et al. Comparison of the levels of the growth factors in umbilical cord serum and human milk and its clinical significance. Cytokine 2012, 59(2):305-308.
    • (2012) Cytokine , vol.59 , Issue.2 , pp. 305-308
    • Patki, S.1
  • 44
    • 0031889548 scopus 로고    scopus 로고
    • Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology
    • Banks R.E., et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998, 77(6):956-964.
    • (1998) Br J Cancer , vol.77 , Issue.6 , pp. 956-964
    • Banks, R.E.1
  • 45
    • 64849116779 scopus 로고    scopus 로고
    • The role of vascular endothelial growth factor in wound healing
    • Bao P., et al. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009, 153(2):347-358.
    • (2009) J Surg Res , vol.153 , Issue.2 , pp. 347-358
    • Bao, P.1
  • 46
    • 80051800928 scopus 로고    scopus 로고
    • VEGF-A and FGF gene therapy accelerate healing of ischemic colonic anastomoses (experimental study)
    • Adas G., et al. VEGF-A and FGF gene therapy accelerate healing of ischemic colonic anastomoses (experimental study). Int J Surg 2011, 9(6):467-471.
    • (2011) Int J Surg , vol.9 , Issue.6 , pp. 467-471
    • Adas, G.1
  • 49
    • 0033860607 scopus 로고    scopus 로고
    • Is human fracture hematoma inherently angiogenic?
    • Street J., et al. Is human fracture hematoma inherently angiogenic?. Clin Orthop Relat Res 2000, 378:224-237.
    • (2000) Clin Orthop Relat Res , vol.378 , pp. 224-237
    • Street, J.1
  • 50
    • 0037162547 scopus 로고    scopus 로고
    • Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover
    • Street J., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002, 99(15):9656-9661.
    • (2002) Proc Natl Acad Sci USA , vol.99 , Issue.15 , pp. 9656-9661
    • Street, J.1
  • 51
    • 0032965317 scopus 로고    scopus 로고
    • Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
    • Rivard A., et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999, 154(2):355-363.
    • (1999) Am J Pathol , vol.154 , Issue.2 , pp. 355-363
    • Rivard, A.1
  • 52
    • 0031714785 scopus 로고    scopus 로고
    • Increased plasma vascular endothelial growth factor among patients with chronic venous disease
    • Shoab S.S., Scurr J.H., Coleridge-Smith P.D. Increased plasma vascular endothelial growth factor among patients with chronic venous disease. J Vasc Surg 1998, 28(3):535-540.
    • (1998) J Vasc Surg , vol.28 , Issue.3 , pp. 535-540
    • Shoab, S.S.1    Scurr, J.H.2    Coleridge-Smith, P.D.3
  • 53
    • 0030724190 scopus 로고    scopus 로고
    • Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury
    • Luo Z., et al. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thoracic Surg 1997, 64(4):993-998.
    • (1997) Ann Thoracic Surg , vol.64 , Issue.4 , pp. 993-998
    • Luo, Z.1
  • 54
    • 0032578961 scopus 로고    scopus 로고
    • Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
    • Losordo D.W., et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998, 98(25):2800-2804.
    • (1998) Circulation , vol.98 , Issue.25 , pp. 2800-2804
    • Losordo, D.W.1
  • 55
    • 0033503798 scopus 로고    scopus 로고
    • Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA
    • [discussion 470-2]
    • Rosengart T.K., et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 1999, 230(4):466-470. [discussion 470-2].
    • (1999) Ann Surg , vol.230 , Issue.4 , pp. 466-470
    • Rosengart, T.K.1
  • 56
    • 84895734499 scopus 로고    scopus 로고
    • VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart
    • Kivela R., et al. VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart. EMBO Mol Med 2014, 6(3):307-321.
    • (2014) EMBO Mol Med , vol.6 , Issue.3 , pp. 307-321
    • Kivela, R.1
  • 57
    • 84896318095 scopus 로고    scopus 로고
    • Cardioprotective effect of VEGF and venom VEGF-like protein in acute myocardial ischemia in mice: effect on mitochondrial function
    • Messadi E., et al. Cardioprotective effect of VEGF and venom VEGF-like protein in acute myocardial ischemia in mice: effect on mitochondrial function. J Cardiovasc Pharmacol 2014, 63(3):274-281.
    • (2014) J Cardiovasc Pharmacol , vol.63 , Issue.3 , pp. 274-281
    • Messadi, E.1
  • 58
    • 84896710527 scopus 로고    scopus 로고
    • The effect of vascular endothelial growth factor overexpression in experimental necrotizing enterocolitis
    • Karatepe H.O., et al. The effect of vascular endothelial growth factor overexpression in experimental necrotizing enterocolitis. Pediatr Surg Int 2014, 30(3):327-332.
    • (2014) Pediatr Surg Int , vol.30 , Issue.3 , pp. 327-332
    • Karatepe, H.O.1
  • 59
    • 37649028033 scopus 로고    scopus 로고
    • Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth
    • Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Syst Rev 2006, (3):CD004454.
    • (2006) Cochrane Syst Rev , Issue.3 , pp. CD004454
    • Roberts, D.1    Dalziel, S.2
  • 60
    • 38349125416 scopus 로고    scopus 로고
    • Localization and control of expression of VEGF-A and the VEGFR-2 receptor in fetal sheep intestines
    • Holmes K., et al. Localization and control of expression of VEGF-A and the VEGFR-2 receptor in fetal sheep intestines. Pediatr Res 2008, 63(2):143-148.
    • (2008) Pediatr Res , vol.63 , Issue.2 , pp. 143-148
    • Holmes, K.1
  • 61
    • 0037967272 scopus 로고    scopus 로고
    • Tumorigenesis and the angiogenic switch
    • Bergers G., Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003, 3(6):401-410.
    • (2003) Nat Rev Cancer , vol.3 , Issue.6 , pp. 401-410
    • Bergers, G.1    Benjamin, L.E.2
  • 63
    • 84921288113 scopus 로고    scopus 로고
    • Effects of tumor microenvironmental factors on VEGF expression
    • Wang F., et al. Effects of tumor microenvironmental factors on VEGF expression. Biomed Rep 2013, 1(4):539-544.
    • (2013) Biomed Rep , vol.1 , Issue.4 , pp. 539-544
    • Wang, F.1
  • 64
    • 0037141345 scopus 로고    scopus 로고
    • Intra-tumoural microvessel density in human solid tumours
    • Hasan J., Byers R., Jayson G.C. Intra-tumoural microvessel density in human solid tumours. Br J Cancer 2002, 86(10):1566-1577.
    • (2002) Br J Cancer , vol.86 , Issue.10 , pp. 1566-1577
    • Hasan, J.1    Byers, R.2    Jayson, G.C.3
  • 65
    • 0032714311 scopus 로고    scopus 로고
    • KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells
    • Yoshiji H., et al. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells. Hepatology 1999, 30(5):1179-1186.
    • (1999) Hepatology , vol.30 , Issue.5 , pp. 1179-1186
    • Yoshiji, H.1
  • 66
    • 84899026220 scopus 로고    scopus 로고
    • Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agents
    • Vano Y.A., et al. Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agents. Exp Rev Anticancer Ther 2014.
    • (2014) Exp Rev Anticancer Ther
    • Vano, Y.A.1
  • 67
    • 0033830523 scopus 로고    scopus 로고
    • Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature
    • Grunstein J., et al. Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature. Mol Cell Biol 2000, 20(19):7282-7291.
    • (2000) Mol Cell Biol , vol.20 , Issue.19 , pp. 7282-7291
    • Grunstein, J.1
  • 68
    • 0034129125 scopus 로고    scopus 로고
    • The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo
    • Zhang H.T., et al. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer 2000, 83(1):63-68.
    • (2000) Br J Cancer , vol.83 , Issue.1 , pp. 63-68
    • Zhang, H.T.1
  • 69
    • 0000391746 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
    • Bergers G., et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000, 2(10):737-744.
    • (2000) Nat Cell Biol , vol.2 , Issue.10 , pp. 737-744
    • Bergers, G.1
  • 70
    • 84890075029 scopus 로고    scopus 로고
    • Tyrosine phosphorylation modulates the vascular responses of mesenteric arteries from human colorectal tumors
    • Ferrero E., et al. Tyrosine phosphorylation modulates the vascular responses of mesenteric arteries from human colorectal tumors. Biomed Res Int 2013, 2013:545983.
    • (2013) Biomed Res Int , vol.2013 , pp. 545983
    • Ferrero, E.1
  • 71
    • 0036009760 scopus 로고    scopus 로고
    • VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding
    • Soker S., et al. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J Cell Biochem 2002, 85(2):357-368.
    • (2002) J Cell Biochem , vol.85 , Issue.2 , pp. 357-368
    • Soker, S.1
  • 72
    • 0034612203 scopus 로고    scopus 로고
    • Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor
    • Baumgartner I., et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Int Med 2000, 132(11):880-884.
    • (2000) Ann Int Med , vol.132 , Issue.11 , pp. 880-884
    • Baumgartner, I.1
  • 73
    • 0037453099 scopus 로고    scopus 로고
    • The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis
    • Henry T.D., et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003, 107(10):1359-1365.
    • (2003) Circulation , vol.107 , Issue.10 , pp. 1359-1365
    • Henry, T.D.1
  • 74
    • 0037370325 scopus 로고    scopus 로고
    • Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
    • Eremina V., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003, 111(5):707-716.
    • (2003) J Clin Invest , vol.111 , Issue.5 , pp. 707-716
    • Eremina, V.1
  • 75
    • 1542297332 scopus 로고    scopus 로고
    • Pathogenesis of lesions in late age-related macular disease
    • Holz F.G., et al. Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 2004, 137(3):504-510.
    • (2004) Am J Ophthalmol , vol.137 , Issue.3 , pp. 504-510
    • Holz, F.G.1
  • 76
    • 33646816714 scopus 로고    scopus 로고
    • Neovascularization in human atherosclerosis
    • Moreno P.R., et al. Neovascularization in human atherosclerosis. Circulation 2006, 113(18):2245-2252.
    • (2006) Circulation , vol.113 , Issue.18 , pp. 2245-2252
    • Moreno, P.R.1
  • 78
    • 84884808814 scopus 로고    scopus 로고
    • Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis
    • Weidemann A.K., et al. Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clin, Cosmet Invest Dermatol 2013, 6:233-244.
    • (2013) Clin, Cosmet Invest Dermatol , vol.6 , pp. 233-244
    • Weidemann, A.K.1
  • 79
    • 0036068479 scopus 로고    scopus 로고
    • The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis
    • Afuwape A.O., Kiriakidis S., Paleolog E.M. The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histol Histopathol 2002, 17(3):961-972.
    • (2002) Histol Histopathol , vol.17 , Issue.3 , pp. 961-972
    • Afuwape, A.O.1    Kiriakidis, S.2    Paleolog, E.M.3
  • 80
    • 0031837973 scopus 로고    scopus 로고
    • Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease
    • Griga T., et al. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 1998, 33(5):504-508.
    • (1998) Scand J Gastroenterol , vol.33 , Issue.5 , pp. 504-508
    • Griga, T.1
  • 81
    • 0036216571 scopus 로고    scopus 로고
    • Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease
    • Griga T., et al. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 2002, 49(43):116-123.
    • (2002) Hepatogastroenterology , vol.49 , Issue.43 , pp. 116-123
    • Griga, T.1
  • 82
    • 33847016462 scopus 로고    scopus 로고
    • Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha
    • Stannard A.K., et al. Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 2007, 27(3):494-502.
    • (2007) Arterioscler Thromb Vasc Biol , vol.27 , Issue.3 , pp. 494-502
    • Stannard, A.K.1
  • 83
    • 84898543443 scopus 로고    scopus 로고
    • Integrated effects of matrix mechanics and vascular endothelial growth factor (VEGF) on capillary sprouting
    • Wu Y., Al-Ameen M.A., Ghosh G. Integrated effects of matrix mechanics and vascular endothelial growth factor (VEGF) on capillary sprouting. Ann Biomed Eng 2014.
    • (2014) Ann Biomed Eng
    • Wu, Y.1    Al-Ameen, M.A.2    Ghosh, G.3
  • 84
    • 84894256030 scopus 로고    scopus 로고
    • Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing
    • Martino M.M., et al. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science 2014, 343(6173):885-888.
    • (2014) Science , vol.343 , Issue.6173 , pp. 885-888
    • Martino, M.M.1
  • 85
    • 70349850473 scopus 로고    scopus 로고
    • Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle
    • Deasy B.M., et al. Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther: J Am Soc Gene Ther 2009, 17(10):1788-1798.
    • (2009) Mol Ther: J Am Soc Gene Ther , vol.17 , Issue.10 , pp. 1788-1798
    • Deasy, B.M.1
  • 86
    • 33751210105 scopus 로고    scopus 로고
    • VEGF at the neurovascular interface: therapeutic implications for motor neuron disease
    • Lambrechts D., Carmeliet P. VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochim Biophys Acta 2006, 1762(11-12):1109-1121.
    • (2006) Biochim Biophys Acta , vol.1762 , Issue.11-12 , pp. 1109-1121
    • Lambrechts, D.1    Carmeliet, P.2
  • 87
    • 57349177854 scopus 로고    scopus 로고
    • VEGF is critical for stem cell-mediated cardio protection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function
    • Markel T.A., et al. VEGF is critical for stem cell-mediated cardio protection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol. Heart Circ Physiol 2008, 295(6):H2308-H2314.
    • (2008) Am J Physiol. Heart Circ Physiol , vol.295 , Issue.6 , pp. H2308-H2314
    • Markel, T.A.1
  • 88
    • 0032853603 scopus 로고    scopus 로고
    • Vascular endothelial growth factor and diabetes - the agonist versus antagonist paradox
    • Duh E., Aiello L.P. Vascular endothelial growth factor and diabetes - the agonist versus antagonist paradox. Diabetes 1999, 48(10):1899-1906.
    • (1999) Diabetes , vol.48 , Issue.10 , pp. 1899-1906
    • Duh, E.1    Aiello, L.P.2
  • 89
    • 0032710319 scopus 로고    scopus 로고
    • Clinical applications of angiogenic growth factors and their inhibitors
    • Ferrara N., Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999, 5(12):1359-1364.
    • (1999) Nat Med , vol.5 , Issue.12 , pp. 1359-1364
    • Ferrara, N.1    Alitalo, K.2
  • 90
    • 84908658539 scopus 로고    scopus 로고
    • Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats
    • Chaudagar K.K., Mehta A.A. Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats. Clin Exp Hypertens 2014, 15-16.
    • (2014) Clin Exp Hypertens , pp. 15-16
    • Chaudagar, K.K.1    Mehta, A.A.2
  • 91
    • 84888043127 scopus 로고    scopus 로고
    • Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart
    • Ishimaru K., et al. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart. J Thoracic Cardiovasc Surg 2013, 146(6):1516-1525.
    • (2013) J Thoracic Cardiovasc Surg , vol.146 , Issue.6 , pp. 1516-1525
    • Ishimaru, K.1
  • 92
    • 84890620046 scopus 로고    scopus 로고
    • Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia
    • Lee H.J., et al. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, restores alveolar and pulmonary vascular development in a rat model of bronchopulmonary dysplasia. Yonsei Med J 2014, 55(1):99-106.
    • (2014) Yonsei Med J , vol.55 , Issue.1 , pp. 99-106
    • Lee, H.J.1
  • 93
    • 0037423321 scopus 로고    scopus 로고
    • Angiogenesis-independent endothelial protection of liver: role of VEGFR-1
    • LeCouter J., et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003, 299(5608):890-893.
    • (2003) Science , vol.299 , Issue.5608 , pp. 890-893
    • LeCouter, J.1
  • 94
    • 0036665610 scopus 로고    scopus 로고
    • Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study
    • Makinen K., et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther: J Am Soc Gene Ther 2002, 6(1):127-133.
    • (2002) Mol Ther: J Am Soc Gene Ther , vol.6 , Issue.1 , pp. 127-133
    • Makinen, K.1
  • 95
    • 0038644624 scopus 로고    scopus 로고
    • Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis
    • Xia Y.P., et al. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 2003, 102(1):161-168.
    • (2003) Blood , vol.102 , Issue.1 , pp. 161-168
    • Xia, Y.P.1
  • 97
    • 84921282728 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF), platelet derived growth factor (PDGF), hepatocyte growth factor (HGF) in patients with acute coronary syndrome (ACS). In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US). [cited 2014 Aug 1].
    • Institute of Cardiology, Warsaw, Poland. Vascular endothelial growth factor (VEGF), platelet derived growth factor (PDGF), hepatocyte growth factor (HGF) in patients with acute coronary syndrome (ACS). In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US). 2000 [cited 2014 Aug 1]. http://clinicaltrials.gov/.
    • (2000)
  • 98
    • 67649236985 scopus 로고    scopus 로고
    • Effect of cardiac rehabilitation on angiogenic cytokines in postinfarction patients
    • Lee B.C., et al. Effect of cardiac rehabilitation on angiogenic cytokines in postinfarction patients. Heart 2009, 95(12):1012-1018.
    • (2009) Heart , vol.95 , Issue.12 , pp. 1012-1018
    • Lee, B.C.1
  • 99
    • 84873208224 scopus 로고    scopus 로고
    • Concentration of vascular endothelial growth factor in patients with acute coronary syndrome
    • Konopka A., et al. Concentration of vascular endothelial growth factor in patients with acute coronary syndrome. Cytokine 2013, 61(2):664-669.
    • (2013) Cytokine , vol.61 , Issue.2 , pp. 664-669
    • Konopka, A.1
  • 100
    • 84921261074 scopus 로고    scopus 로고
    • Induced Angiogenesis by Genic Therapy in Advanced Ischemic Cardiomyopathy (THEANGIOGEN). In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US); [cited 2014 July 9].
    • Instituto de Cardiologia do Rio Grande do Sul. Induced Angiogenesis by Genic Therapy in Advanced Ischemic Cardiomyopathy (THEANGIOGEN). In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US); 2000 [cited 2014 July 9]. http://clinicaltrials.gov/.
    • (2000)
  • 101
    • 84921286834 scopus 로고    scopus 로고
    • NOGA angiogenesis revascularization therapy: evaluation by radionuclide imaging - the northern trial. In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US); [cited 2014 July 9].
    • St. Michael's Hospital, Toronto. NOGA angiogenesis revascularization therapy: evaluation by radionuclide imaging - the northern trial. In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US); 2000 [cited 2014 July 9]. http://clinicaltrials.gov.
    • (2000)
  • 102
    • 84921317685 scopus 로고    scopus 로고
    • Angiogenesis using VEGF-A165/bFGF plasmid delivered percutaneously in no-option CAD patients; a controlled trial (VIF-CAD). In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US); [cited 2014 Aug 1].
    • Institute of Cardiology, Warsaw, Poland. Angiogenesis using VEGF-A165/bFGF plasmid delivered percutaneously in no-option CAD patients; a controlled trial (VIF-CAD). In: ClinicalTrials.gov. [Internet], Bethesda (MD): National Library of Medicine (US); 2000 [cited 2014 Aug 1]. http://clinicaltrials.gov.
    • (2000)
  • 103
    • 84885131010 scopus 로고    scopus 로고
    • High doses of vascular endothelial growth factor 165 safely, but transiently, improve myocardial perfusion in no-option ischemic disease
    • Giusti I.I., et al. High doses of vascular endothelial growth factor 165 safely, but transiently, improve myocardial perfusion in no-option ischemic disease. Hum Gene Ther Methods 2013, 24(5):298-306.
    • (2013) Hum Gene Ther Methods , vol.24 , Issue.5 , pp. 298-306
    • Giusti, I.I.1
  • 104
    • 79952447660 scopus 로고    scopus 로고
    • Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD)
    • Kukula K., et al. Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD). Am Heart J 2011, 161(3):581-589.
    • (2011) Am Heart J , vol.161 , Issue.3 , pp. 581-589
    • Kukula, K.1
  • 105
    • 84921303616 scopus 로고    scopus 로고
    • Kasiak Research Pvt. Ltd. To evaluate the safety and efficacy of IM and IV administration of autologous ADMSC's for treatment of CLI. In: ClinicalTrials.gov [Internet], Bethesda (MD): National Library of Medicine (US); [cited 2014 July 9].
    • Kasiak Research Pvt. Ltd., Kasiak Research Pvt. Ltd. To evaluate the safety and efficacy of IM and IV administration of autologous ADMSC's for treatment of CLI. In: ClinicalTrials.gov [Internet], Bethesda (MD): National Library of Medicine (US); 2000 [cited 2014 July 9]. http://clinicaltrials.gov/.
    • (2000)
  • 106
    • 84921266475 scopus 로고    scopus 로고
    • Northwestern University. VEGF gene transfer for critical limb ischemia. In: ClinicalTrials.gov [Internet] Bethesda (MD): National Library of Medicine (US); [cited 2014 July 9].
    • Douglas Losordo MD. Northwestern University. VEGF gene transfer for critical limb ischemia. In: ClinicalTrials.gov [Internet] Bethesda (MD): National Library of Medicine (US); 2000 [cited 2014 July 9]. http://clinicaltrials.gov/.
    • (2000)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.